Advanced Filters
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
noise

Found 6,931 clinical trials

K Kazumoto Shibuya, PhD, MD

Clinical Trial of Mexiletine Hydrochloride for Spinal and Bulbar Muscular Atrophy

The purpose of this clinical trial is to evaluate the efficacy and safety of mexiletine hydrochloride in patients with spinal and bulbar muscular atrophy.The main questions it aims to answer are:Does mexiletine hydrochloride improve the ALSFRS-R score in spinal and bulbar muscular atrophy patients?Participants will:Take mexiletine hydrochloride or a placebo …

18-80 years Male Phase 2/3
S Sidney Schoenrock, MA

Stimulating the Aging Brain Using Brain and Sensory Stimulation

The goal of this project is to investigate whether transcranial electrical stimulation and sensory stimulation affect language outcomes in individuals with primary progressive aphasia (PPA). The main questions it aims to answer are:Does transcranial alternating current stimulation (tACS) affect verbal short-term memory (STM) in individuals with PPA? Does a single …

45 years and older All Phase N/A
D DRI

Social & Affective Cognition in Alzheimer's Disease & Associated Disorders

Recent studies have shown that individual neuropsychological scores of patients with Alzheimer's disease and Associated Disorders (ADAD) are only poorly correlated to their behavioral difficulties, such as disinhibition, apathy, social decision-making or vulnerability. Recently, social & affective cognitive disorders have been highlighted as potential cause of social behavioral abnormalities. However, …

40-85 years All Phase N/A

Inspiratory Muscle Training in Amiotrophyc Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) progressively damages the nerve cells responsible for voluntary muscle movement. Over time, this leads to weakness in different muscles such as those used for movement or breathing. Breathing problems are one of the main causes of complications and reduced survival in people with ALS. This happens …

18-85 years All Phase N/A

VRehab-SMA Phase 1.2

Spinal muscular atrophy is a genetic disorder characterized by progressive muscle weakness, severely impacting patients' motor abilities. Several disease modifying therapies have been developed to treat Spinal muscular atrophy which have led to new disease trajectories . According to standard of care guidelines, exercise programs should be designed and monitored …

6-18 years All Phase N/A
S Sarah M Boland, CCRP

Longitudinal Multi-Modality Imaging in Progressive Apraxia of Speech

The study is designed to determine the relationship between structural and functional changes in the brain on imaging and progression of speech and language, neurological and neuropsychological features in patients with neurodegenerative apraxia of speech (AOS).

18 years and older All Phase 4
C Camille Wagner Rodriguez, MS

Intervention for Communication Quality of Life in Primary Progressive Aphasia

The goal of this clinical trial is to learn whether a personalized, multi-component, virtual speech language treatment program can improve communication and quality of life for adults with primary progressive aphasia (PPA) and their primary communication partners. The study will enroll participants who speak English and/or Spanish.The main questions the …

40 years and older All Phase N/A
D Dorothee Rickert, Prof. Dr.

SUPRATHEL 250 as a Treatment for Oropharyngeal Wounds

To assess the use of Suprathel 250 for mucosal reconstruction in oropharyngeal defects. The membrane will be applied after tonsillectomy procedures and compared to bare wounds' healing

18 years and older All Phase N/A
J Junfeng Lu, Dr.

Research on Wireless Brain Implant System for General Control of External Devices

The clinical trial aims to evaluate the safety and efficacy of the minimally invasive, wireless brain-machine interface system (WRS) in enabling general brain control of external devices, such as a cursor and other assistive technologies, for paralyzed and amputee patients.WRS integrates a high-throughput, ultra-flexible neural electrode with an extremely small …

18-80 years All Phase N/A
C Camille Wagner Rodriguez, MS

Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia

Difficulties with speech and language are the first and most notable symptoms of primary progressive aphasia (PPA). While there is evidence that demonstrates positive effects of speech-language treatment for individuals with PPA who only speak one language (monolinguals), there is a significant need for investigating the effects of treatment that …

40 years and older All Phase N/A

Simplify language using AI